Approval · Notice of Compliance 245 · 2002
EMINASE: Notice of Compliance 245
Issued January 23, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 245
- Date
- January 23, 2002
- Company
- WellSpring Pharmaceutical Canada Corp.Halifax, Nova Scotia, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Fibrinolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMINASE | 02229390 | Cancelled Post Market |
Medicinal ingredients
- APSAC 30 UNIT per 5ML